← Back to Search

Melatonin supplementation for Sleep Disorder

N/A
Waitlist Available
Research Sponsored by Rothman Institute Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient willing and able to complete postoperative surveys
Patients who undergo primary ARCR
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks post-surgery
Awards & highlights

Study Summary

The purpose of this study is to investigate if oral melatonin reduces postoperative sleep 18 disturbances and narcotics use. We will enroll patients undergoing primary arthroscopic rotator 19 cuff repair (ARCR) at the Rothman Institute.

Eligible Conditions
  • Sleep Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pittsburg Sleep Quality Index (PSQI)

Trial Design

2Treatment groups
Active Control
Group I: No supplementationActive Control1 Intervention
Group II: Melatonin supplementationActive Control1 Intervention
5mg melatonin tablets to be taken for 6 weeks

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
121 Previous Clinical Trials
21,498 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Mar 2025